Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease

References

• Early Treatment Diabetic Retinopathy Study Research GroupEarly photocoagulation for diabetic retinopathy. ETDRS report number 9Ophthalmology199198Suppl 57667852062512
   PubMed Web of Science ®Google Scholar
• The Branch Vein Occlusion Study GroupArgon laser photocoagulation for macular edema in branch vein occlusionAm J Ophthalmol19849832712826383055
   PubMed Web of Science ®Google Scholar
• ThakkerGDHajjarDPMullerWARosengartTKThe role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signalingJ Biol Chem199927415100021000710187776
   PubMed Web of Science ®Google Scholar
• TiltonRGChangKCLeJeuneWSStephanCCBrockTAWilliamsonJRRole for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGFInvest Ophthalmol Vis Sci199940368969610067972
   PubMed Web of Science ®Google Scholar
• BernatchezPNRollinSSokerSSiroisMGRelative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: role of neuropilin-1J Cell Biochem200285362963911968003
   PubMed Web of Science ®Google Scholar
• MarnerosAGFanJYokoyamaYVascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual functionAm J Pathol200516751451145916251428
   PubMed Web of Science ®Google Scholar
• Saint-GeniezMMaldonadoAED’AmorePAVEGF expression and receptor activation in the choroid during development and in the adultInvest Ophthalmol Vis Sci20064773135314216799060
   PubMed Web of Science ®Google Scholar
• HaighJJRole of VEGF in organogenesisOrganogenesis20084424725619337405
   PubMedGoogle Scholar
• FerraraNVascular endothelial growth factor: basic science and clinical progressEndocr Rev200425458161115294883
   PubMed Web of Science ®Google Scholar
• FunatsuHYamashitaHNomaHMimuraTYamashitaTHoriSIncreased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edemaAm J Ophthalmol20021331707711755841
   PubMed Web of Science ®Google Scholar
• OzakiHHayashiHVinoresSAMoromizatoYCampochiaroPAOshimaKIntravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood–retinal barrier in rabbits and primatesExp Eye Res19976445055179227268
   PubMed Web of Science ®Google Scholar
• DvorakHFBrownLFDetmarMDvorakAMVascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisAm J Pathol19951465102910397538264
   PubMed Web of Science ®Google Scholar
• ChangTSBresslerNMFineJTDolanCMWardJKlesertTRImproved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trialArch Ophthalmol2007125111460146917998507
   PubMedGoogle Scholar
• KookDWolfAKreutzerTLong-term effect of intravitreal bevacizumab (Avastin) in patients with chronic diffuse diabetic macular edemaRetina20082881053106018779710
   PubMed Web of Science ®Google Scholar
• PragerFMichelsSKriechbaumKIntravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trialBr J Ophthalmol200993445245619074916
   PubMed Web of Science ®Google Scholar
• KondoMKondoNItoYIntravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12 months and multiple regression analysisRetina20092991242124819672216
   PubMed Web of Science ®Google Scholar
• NguyenQDBrownDMMarcusDMRanibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEOphthalmology2012119478980122330964
   PubMed Web of Science ®Google Scholar
• MitchellPBandelloFSchmidt-ErfurthUThe RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology2011118461562521459215
   PubMed Web of Science ®Google Scholar
• GregoriNZGaitanJRosenfeldPJLong-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusionRetina20082891325133719430392
   PubMed Web of Science ®Google Scholar
• GregoriNZRattanGHRosenfeldPJSafety and efficacy of intravitreal bevacizumab (Avastin) for the management of branch and hemiretinal vein occlusionRetina200929791392519584649
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMAwhCCSustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III studyOphthalmology2011118102041204921715011
   PubMed Web of Science ®Google Scholar
• HeierJSCampochiaroPAYauLRanibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trialOphthalmology2012119480280922301066
   PubMed Web of Science ®Google Scholar
• BoyerDHeierJBrownDMVascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS studyOphthalmology201211951024103222440275
   PubMed Web of Science ®Google Scholar
• PapadopoulosNMartinJRuanQBinding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabAngiogenesis201215217118522302382
   PubMed Web of Science ®Google Scholar
• JaissleGBSzurmanPBartz-SchmidtKURecommendation for the implementation of intravitreal injections – statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)Klin Monbl Augenheilkd20052225390395 German15912456
   PubMed Web of Science ®Google Scholar
• ScappaticciFASkillingsJRHoldenSNArterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumabJ Natl Cancer Inst200799161232123917686822
   PubMed Web of Science ®Google Scholar
• CannistraSAMatulonisUAPensonRTPhase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancerJ Clin Oncol200725335180518618024865
   PubMed Web of Science ®Google Scholar
• EreminaVJeffersonJAKowalewskaJVEGF inhibition and renal thrombotic microangiopathyN Engl J Med2008358111129113618337603
   PubMed Web of Science ®Google Scholar
• HurwitzHISaltzLBVan CutsemEVenous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studiesJ Clin Oncol201129131757176421422411
   PubMed Web of Science ®Google Scholar
• SchutzFAJeYAzziGRNguyenPLChoueiriTKBevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomesAnn Oncol20112261404141221115602
   PubMed Web of Science ®Google Scholar
• PragerGWBreussJMSteurerSMihalyJBinderBRVascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cellsBlood2004103395596214525763
   PubMed Web of Science ®Google Scholar
• PetersSHeiduschkaPJulienSZiemssenFFietzHBartz-SchmidtKUUltrastructural findings in the primate eye after intravitreal injection of bevacizumabAm J Ophthalmol20071436995100217449002
   PubMed Web of Science ®Google Scholar
• MeyerTRobles-CarrilloLRobsonTBevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic miceJ Thromb Haemost20097117118118983497
   PubMed Web of Science ®Google Scholar
• VidinovaCVidinovNThe effect of bevacizumab on the ultrastructure of choroidal neovascular membranes in patients with age-related macular degeneration (AMD)Klin Monbl Augenheilkd20092266491495 German19507100
   PubMed Web of Science ®Google Scholar
• PapadopoulouDNMendrinosEMangiorisGDonatiGPournarasCJIntravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degenerationOphthalmology200911691755176119560206
   PubMed Web of Science ®Google Scholar
• SacuSPempBWeigertGResponse of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusionInvest Ophthalmol Vis Sci20115263046305021051706
   PubMed Web of Science ®Google Scholar
• SolimanWVintenMSanderBOptical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedemaActa Ophthalmol200886436537118028237
   PubMed Web of Science ®Google Scholar
• FeuchtNMatthiasHLohmannCPMaierMPegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in GermanyClin Ophthalmol20082225325919668713
   PubMedGoogle Scholar
• FungAERosenfeldPJReichelEThe International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwideBr J Ophthalmol200690111344134916854824
   PubMed Web of Science ®Google Scholar
• RosenfeldPJRichRMLalwaniGARanibizumab: phase III clinical trial resultsOphthalmol Clin North Am200619336137216935211
   PubMedGoogle Scholar
• BrownDMKaiserPKMichelsMRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med2006355141432144417021319
   PubMed Web of Science ®Google Scholar
• van der ReisMILa HeijECDe Jong-HesseYRingensPJHendrikseFSchoutenJSA systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injectionsRetina20113181449146921817960
   PubMed Web of Science ®Google Scholar
• YokoyamaKChoshiTKimotoKShinodaKNakatsukaKRetinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucomaActa Ophthalmol200886892792818494739
   PubMed Web of Science ®Google Scholar
• KimKSChangHRSongSIschaemic change after intravitreal bevacizumab (Avastin) injection for macular oedema secondary to non-ischaemic central retinal vein occlusionActa Ophthalmol200886892592718494740
   PubMed Web of Science ®Google Scholar
• HuangZLLinKHLeeYCSheuMMTsaiRKAcute vision loss after intravitreal injection of bevacizumab (Avastin) associated with ocular ischemic syndromeOphthalmologica20102242868919707032
   PubMed Web of Science ®Google Scholar
• MansourAMShahinMKofoedPKParodiMBShamiMSchwartzSGInsight into 144 patients with ocular vascular events during VEGF antagonist injectionsClin Ophthalmol2012634336322419856
   PubMedGoogle Scholar
• NeubauerASKookDHaritoglouCBevacizumab and retinal ischemiaOphthalmology200711411209617980746
   PubMed Web of Science ®Google Scholar
• TeruiTKondoMSugitaTChanges in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusionRetina20113161068107421451440
   PubMed Web of Science ®Google Scholar
• ChungEJRohMIKwonOWKohHJEffects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edemaRetina200828795796318698297
   PubMed Web of Science ®Google Scholar
• MirshahiARoohipoorRLashayAMohammadiSFAbdoallahiAFaghihiHBevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trialEur J Ophthalmol200818226326918320520
   PubMed Web of Science ®Google Scholar